GeoVax Provides Progress Report on Its Ebola Vaccine Program | 8:00 AM |
[Marketwired] - GeoVax Labs, Inc. , a biotechnology company developing innovative human vaccines using its unique vaccine delivery platform, today provided an update on its Ebola virus vaccine development program.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.